These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6886409)

  • 41. Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis.
    Al-Khayatt R; Jennings R; Potter CW
    J Hyg (Lond); 1984 Oct; 93(2):301-12. PubMed ID: 6389697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human sera possess a limited antibody repertoire to influenza neuraminidase antigenic variants selected in vitro.
    Natali A; Panizzi PF; Chezzi C; Oxford JS
    J Hyg (Lond); 1984 Apr; 92(2):243-50. PubMed ID: 6707473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of anti-neuraminidase antibody titres in human sera by inhibition of the agglutination of fetuin-latex by influenza viruses.
    Aymard M; Quash GA; Million J
    J Biol Stand; 1982 Apr; 10(2):125-33. PubMed ID: 7096361
    [No Abstract]   [Full Text] [Related]  

  • 44. Immune response to influenza vaccination in an elderly population.
    Brydak LB; Machała M; Myśliwska J; Myśliwski A; Trzonkowski P
    J Clin Immunol; 2003 May; 23(3):214-22. PubMed ID: 12797543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of antineuraminidase antibody in immunity to influenza virus infection.
    Schulman JL
    Bull World Health Organ; 1969; 41(3):647-50. PubMed ID: 5309490
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience.
    Johansson BE; Moran TM; Bona CA; Popple SW; Kilbourne ED
    J Immunol; 1987 Sep; 139(6):2010-4. PubMed ID: 3624874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection.
    Beutner KR; Chow T; Rubi E; Strussenberg J; Clement J; Ogra PL
    J Infect Dis; 1979 Dec; 140(6):844-50. PubMed ID: 396336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative immunogenicity of live influenza viruses and their solubilized neuraminidases: results of mouse protection experiments.
    Bottex C; Burckhart MF; Fontanges R
    Arch Virol; 1981; 70(2):83-9. PubMed ID: 7332493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody status to influenza A/Singapore/1/57(H2N2) in Finland during a period of outbreaks caused by H3N2 and H1N1 subtype viruses.
    Pyhälä R
    J Hyg (Lond); 1985 Oct; 95(2):437-45. PubMed ID: 4067298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus.
    Clements ML; Betts RF; Tierney EL; Murphy BR
    J Clin Microbiol; 1986 Jul; 24(1):157-60. PubMed ID: 3722363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Reactivity and immunologic activity of polyvalent split influenza vaccine in children].
    Závadová H; Domorázková E; Skovránková J; Vodicková M; Ragac P; Vonka V
    Cesk Pediatr; 1990 Jun; 45(6):344-6. PubMed ID: 2289253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Influenza viruses which preconditioned the epidemic rise in Russia in 2002-2003. A resumed circulation of influenza viruses similar to V/Victoria/2/87].
    Ivanova VT; Burtseva EI; Slepushkin AN; Oskerko TA; Zagorskaia IuV; Shevchenko ES; Mashkova SA; Feodoritova EL
    Vopr Virusol; 2004; 49(3):12-7. PubMed ID: 15188649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.
    Sugaya N; Nerome K; Ishida M; Matsumoto M; Mitamura K; Nirasawa M
    JAMA; 1994 Oct; 272(14):1122-6. PubMed ID: 7933325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Postvaccinal anti-influenza immunity and its determining factors].
    Kastrikina LN; Lonskaia NI
    Vopr Virusol; 1990; 35(5):362-7. PubMed ID: 2267774
    [No Abstract]   [Full Text] [Related]  

  • 56. Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines.
    Slepushkin AN; Schild GC; Beare AS; Chinn S; Tyrrell DA
    J Hyg (Lond); 1971 Dec; 69(4):571-8. PubMed ID: 5002644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans.
    Kilbourne ED
    J Infect Dis; 1976 Oct; 134(4):384-94. PubMed ID: 789791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season.
    Pyhälä R; Ikonen N; Santanen R; Haanpää M; Visakorpi R; Jäppinen P; Valle M
    J Med Virol; 2001 Nov; 65(3):584-9. PubMed ID: 11596097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.
    Powers DC; Kilbourne ED; Johansson BE
    Clin Diagn Lab Immunol; 1996 Sep; 3(5):511-6. PubMed ID: 8877127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection.
    Oxford JS; Schild GC; Potter CW; Jennings R
    J Hyg (Lond); 1979 Feb; 82(1):51-61. PubMed ID: 105040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.